ReViral

Halo Therapeutics

This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.

Altesa BioSciences

This company develops antiviral medicines for patients with chronic lung diseases such as COPD and asthma to prevent respiratory infections and illness flare-ups.

Pneumagen

This clinical-stage biotech company develops intranasal antiviral drugs to prevent and treat respiratory tract infections for patients with chronic lung diseases.

Vicebio

This biopharmaceutical company develops multivalent vaccines for respiratory viral infections targeting older adults and immunocompromised patients.

Agenovir

This company develops nuclease-based anti-viral therapeutics to eliminate pathogenic viral genomes for healthcare providers treating patients with persistent viral infections.

Adagio Therapeutics

This biopharmaceutical company develops monoclonal antibody therapies for the prevention and treatment of viral respiratory diseases, primarily serving immunocompromised patients.

Aerium Therapeutics

This biopharmaceutical company develops monoclonal antibodies and antiviral treatments to protect immunocompromised patients against COVID-19 and future epidemic threats.

ViroVet

This company develops vaccines and antiviral drugs for livestock to control respiratory diseases and other viral infections in cattle, swine, sheep and goats.